Tag: COVID-19

The new immunity toolkit

September 7, 2021

By Susan Bowerman, Senior Director Worldwide Nutrition Education and Training, Herbalife Nutrition The most recent development in world of health and medicine has been the acceptance that we will be living with COVID-19 into the longer term. Masks, social distancing, vaccine passports and travel restrictions will now bean inseparable part of our daily dealings. While […]

Continue Reading

Thailand’s winning strategies amid the health crisis

September 6, 2021

By Roshel Jayasundera,Senior Director, Global Consulting, Axios International Roshel Jayasundera of Axios International, anInternational firm who is focusing on the emerging market including Asia, Africa, Europe, Latin America and Middle East, discussed current healthcare trends in Thailand and Southeast Asia, as well as how Thailand is recovering from the Covid-19 outbreak, in this article. How […]

Continue Reading

Antibodies against COVID-19 vary with vaccination vs natural infection

August 27, 2021

New research conducted at Rockefeller’s Laboratory of Molecular Immunology in New York suggests a natural infection may induce maturation of antibodies with broader activity than that conferred by an [mRNA] vaccination. While vaccination produces greater amounts of circulating antibodies than natural infection, the overall antibody response, or memory B cells, birthed from a natural infection […]

Continue Reading

TikTok, MyHealthKKM partner for COVID-19 awareness campaign

August 20, 2021

Creative video platform TikTok has partnered with MyHealthKKM, the Education Health Division of the Ministry of Health, Malaysia, to start a COVID-19 public health awareness campaign tagged, “#KitaJagaKita” that advocates for mass vaccinations. The campaign aims to provide easily accessible – and most importantly – verified information and resources related to the pandemic. Users on […]

Continue Reading

COVID-19 vaccination effective against delta variant, researchers say

August 20, 2021

Researchers at Washington University School of Medicine in St. Louis (WUSTL) have found that the delta variant of the virus causing COVID-19 is not more resistant to antibodies elicited by vaccination. According to WUSTL associate professor of medicine Dr. Jacco Boon, the delta variant is “[not evidently] better at overcoming vaccine-induced immunity compared to other […]

Continue Reading

Prenetics HK launches home rapid detection kit for COVID-19

August 12, 2021

Hong Kong-based Prenetics Ltd. (Prenetics) has launched a reusable rapid detection system – Circle HealthPod (HealthPod) – for kit at home. The technology behind the HealthPod was developed at Oxford University and boasts a sensitivity of 96% and specificity of 99.9% when it comes to COVID-19 detection. Prenetics has been selected by the Hong Kong […]

Continue Reading

Cambodia to mix vaccines as booster shots in COVID-19 fight

August 2, 2021

Cambodia will begin offering a third vaccination dose to nearly one million frontline workers in the country as a measure against COVID-19. Prime Minister Hun Sen said Cambodia will be switching between the AstraZeneca (AZ) and Chinese COVID-19 vaccines – those initially vaccinated with Sinopharm/Sinovac will be given a third booster AZ dose, and vice-versa. […]

Continue Reading

Ivermectin under scrutiny as possible COVID-19 treatment

July 30, 2021

The Principle Trial organised by scientists at the University of Oxford, UK, is currently administering Ivermectin to COVID-19 patients to see if the drug prevents severe disease. Ivermectin is an anti-parasitic drug commonly used as veterinary medication – it has become controversial after being promoted for use in many parts of the world, despite its […]

Continue Reading

Antibodies produced in response to COVID-19 may trigger blood clots

July 29, 2021

A study of the antibodies naturally produced to fight SARS-CoV-2’s spike protein was found to differ from the antibodies of healthy individuals, according to researchers at the University of Reading (Reading), UK. It may also be triggering an exaggerated platelet response, which could lead to fatal blood clots in patients with severe disease. Platelets are […]

Continue Reading

AztraZeneca’s Vaxzevria, highly effective after one dose vs Delta variants – Study

July 26, 2021

Vaxzevria, formerly AZD1222, was the Covid-19 vaccine co-invented by the University of Oxford and its spin-out company, Vaccitech. The vaccine has been granted a conditional marketing authorisation or emergency use in more than 80 countries across six continents. According to biopharmaceutical company AstraZeneca, over 700 million doses of its Covid-19 vaccine have been supplied to 170 countries worldwide, including […]

Continue Reading

Sex ChatWP-Clear 3.0 Theme